-
1
A CTLA-4 blocking strategy based on Nanoboby in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects
Published 2021-09-01Subjects: Get full text
Article -
2
CTLA-4 gene mutation and multiple sclerosis: A case report and literature review
Published 2022-06-01Subjects: Get full text
Article -
3
Role of cytotoxic T-lymphocyte antigen 4 (CTLA-4) expression in the pathogenesis of Warthin’s tumor growth
Published 2022-12-01Subjects: “…cytotoxic t-lymphocyte antigen-4 (ctla-4)…”
Get full text
Article -
4
-
5
Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit
Published 2017-02-01Subjects: “…cytotoxic t lymphocyte antigen-4…”
Get full text
Article -
6
Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma
Published 2021-05-01Subjects: “…Soluble cytotoxic T-lymphocyte antigen 4(sCTLA-4)…”
Get full text
Article -
7
Top 100 Most Cited Publications on CTLA-4 Molecule in Cancer Research: A Bibliometric Analysis
Published 2023-01-01Subjects: Get full text
Article -
8
CD80 and CTLA-4 as diagnostic and prognostic markers in adult-onset minimal change disease: a retrospective study
Published 2018-08-01Subjects: Get full text
Article -
9
-
10
Effect of Cytotoxic T-Lymphocyte Antigen-4 on the Efficacy of the Fatty Acid-Binding Protein Vaccine Against Schistosoma japonicum
Published 2019-05-01Subjects: Get full text
Article -
11
Meta-analysis of interrelation between cytotoxic T-lymphocyte antigen-4 (+49A>G) polymorphism and recurrent spontaneous abortion
Published 2023-01-01Subjects: Get full text
Article -
12
Relationship Between the Expression of PD-1 and CTLA-4 on T Lymphocytes and the Severity and Prognosis of Sepsis
Published 2023-04-01Subjects: Get full text
Article -
13
Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients
Published 2022-10-01Subjects: “…soluble form of cytotoxic‐T‐lymphocyte‐antigen‐4…”
Get full text
Article -
14
Biological mechanisms of resistance to immune checkpoint inhibitors and overcoming this resistance: Challenges in medical oncology
Published 2024-02-01Subjects: “…immunotherapy; cancer; tumor microenvironment; mechanisms; cytotoxic t-lymphocyte antigen-4; programmed cell death protein 1…”
Get full text
Article -
15
-
16
Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy
Published 2023-03-01Subjects: Get full text
Article -
17
Heterogeneous tumor‐immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti‐PD‐L1 antibody therapy
Published 2021-02-01Subjects: Get full text
Article -
18
Cytotoxic T-lymphocyte antigen-4 +49A/G polymorphisms in Sudanese adults with type 1 diabetes and latent autoimmune diabetes
Published 2019-11-01Subjects: Get full text
Article -
19
Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
Published 2023-06-01Subjects: “…cytotoxic T-lymphocyte antigen 4 (CTLA-4)…”
Get full text
Article -
20
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
Published 2022-11-01Subjects: “…cytotoxic T-lymphocyte antigen 4 (CTLA-4)…”
Get full text
Article